These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1160 related items for PubMed ID: 15985341
1. The future of 'pure' medical science: the need for a new specialist professional research system. Charlton BG, Andras P. Med Hypotheses; 2005; 65(3):419-25. PubMed ID: 15985341 [Abstract] [Full Text] [Related]
2. Conflicts of interest in medical science: peer usage, peer review and 'CoI consultancy'. Charlton BG. Med Hypotheses; 2004; 63(2):181-6. PubMed ID: 15236772 [Abstract] [Full Text] [Related]
3. Medical research funding may have over-expanded and be due for collapse. Charlton BG, Andras P. QJM; 2005 Jan; 98(1):53-5. PubMed ID: 15625354 [Abstract] [Full Text] [Related]
5. Mega-prizes in medicine: big cash awards may stimulate useful and rapid therapeutic innovation. Charlton BG. Med Hypotheses; 2007 Oct; 68(1):1-3. PubMed ID: 17052861 [Abstract] [Full Text] [Related]
6. [Issues of research in medicine]. Topić E. Acta Med Croatica; 2006 Oct; 60 Suppl 1():5-16. PubMed ID: 16526304 [Abstract] [Full Text] [Related]
7. Experience of King Abdul-Aziz City for science and technology in funding medical research in Saudi Arabia. Alabdula'aly AI. Saudi Med J; 2004 Jan; 25(1 Suppl):S8-12. PubMed ID: 14968184 [Abstract] [Full Text] [Related]
9. [Clinical research: where does it come from? Where is it going?]. Vallotton MB. Schweiz Med Wochenschr; 1995 Dec 02; 125(48):2315-21. PubMed ID: 8539579 [Abstract] [Full Text] [Related]
10. Why medical research needs a new specialty of 'pure medical science'. Charlton BG. Clin Med (Lond); 2006 Dec 02; 6(2):163-5. PubMed ID: 16688974 [Abstract] [Full Text] [Related]
11. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE, Kleijnen J. Eur J Health Econ; 2008 Nov 02; 9 Suppl 1():5-29. PubMed ID: 18987905 [Abstract] [Full Text] [Related]
12. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE, Kleijnen J. Dtsch Med Wochenschr; 2008 Dec 02; 133 Suppl 7():S225-46. PubMed ID: 19034813 [Abstract] [Full Text] [Related]
13. Boom or bubble? Is medical research thriving or about to crash? Charlton BG. Med Hypotheses; 2006 Dec 02; 66(1):1-2. PubMed ID: 16242249 [Abstract] [Full Text] [Related]
14. SysBioMed report: advancing systems biology for medical applications. Wolkenhauer O, Fell D, De Meyts P, Blüthgen N, Herzel H, Le Novère N, Höfer T, Schürrle K, van Leeuwen I. IET Syst Biol; 2009 May 02; 3(3):131-6. PubMed ID: 19449974 [Abstract] [Full Text] [Related]
15. [Towards a new equitable system of scientific publications]. Vizcaíno-Salazar G. Invest Clin; 2009 Jun 02; 50(2):141-3. PubMed ID: 19662809 [Abstract] [Full Text] [Related]
18. Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death". Roberts SF, Fischhoff MA, Sakowski SA, Feldman EL. Acad Med; 2012 Mar 02; 87(3):266-70. PubMed ID: 22373616 [Abstract] [Full Text] [Related]